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A rapid, simple, and sensitive spectrophotometric method has been described for the determination of nimodipine in bulk drug,
tablets, and injection. The proposed method is based on the diazotization of reduced nimodipine with nitrous acid followed by
coupling with phloroglucinol to form colored azo dye and showing absorption maximum (𝜆max) at 410 nm. The formed colored
azo dye is stable for about more than 2 h. The method obeyed Beer’s law over the concentration range of 0–25𝜇g/mL and the
corresponding molar absorptivity value is 1.23 × 104 L/moL/cm. The Sandell sensitivity values limits of detection (LOD) and
quantification (LOQ) values have also been reported for the developed method. The accuracy and precision of the method was
evaluated on intra- and interday basis; the relative error (%RE) and the relative standard deviation (RSD) were <2.0%. All variables
have been optimized and the presented reaction sequence was applied to the analysis of nimodipine in bulk drug, tablets, and
injections. The performance of this method was evaluated in terms of Student’s 𝑡-test and variance ratio 𝐹-test to find out the
significance of proposed method over the reference method.
1. Introduction
Nimodipine (NMD), chemically known as isopropyl-2-
methoxyethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-
3,5-pyridine dicarboxylate (Figure 1), is a dihydropyridine
calcium channel blocker that acts by relaxing the arterial
smooth muscle. It is known for its preferential action on
cerebral blood vessels and its potential cytoprotective effects
by reducing calcium influx into nerve cells [1]. Nimodipine
has also been used in the other cerebrovascular disorders,
such as ischemic stroke, hypertension, and multi-infarct
dementia [2]. It increases blood flow to injured brain tissues.
It has been officially determined by liquid chromatographic
method with UV detection [3].
Various analytical methods for the measurement of this
compound have been reported. These include HPLC [4],
LC-MS-MS [5], LC-MS [6], and GC with electron capture
detection [7]. These techniques are highly expensive and not
affordable for the routine analysis of dosage forms. Various
analytical techniques that have been reported for this drug in
therapeutics include atomic absorption spectrophotometry
[8], polarography [9], spectrofluorimetry [10], and spectro-
photometry [11–16].
Many of the reported methods are time consuming and
require expensive experimental setup [4–7], and polaro-
graphic methods are less sensitive [9]. Besides, the reported
spectrophotometric methods are less sensitive [11–16] and
require heating conditions [11] and costly chromogenic
reagent [13], (Table 1). Considering these demerits, there was
a need to develop more advantageous spectrophotometric
method for the determination of NMD in bulk sample and
in tablets.
The present investigation reports the development and
validation of a simple, highly sensitive, and accurate method
for the determination of NMD in bulk drug, tablets, and in
injection based on diazo-coupling reaction using phloroglu-
cinol (PG) as the coupling agent. The developed method is
validated for linearity, accuracy, precision, selectivity, and
recovery as per the current ICH guidelines.
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Table 1: Comparison of the performance characteristic of the existing visible spectrophotometric methods with the proposed methods.












Colored azo dye was
measured at 550 nm 0–40.0 Less sensitive [12]
(3) (a) p-Dimethylaminocinnamaldehyde(b) Folin Ciocalteu reagent
The absorbance of Schiff base
was measured at 510 nm
The colored complex was







(4) 𝛽-Naphthol Orange-red colored azo dyemeasured at 555 nm
0–10.0
(C = 7.74 × 102) Less sensitive [14]
(5) Metol-dichromate Charge transfer complexmeasured at 520 nm
0–70.0





(6) Phloroglucinol Yellow colored azo dyemeasured at 410 nm
0–25














Figure 1: Structures of NMD.
2. Experimental Section
2.1. Apparatus. All spectral and absorbance measurements
were performed using a Systronics Model 166 digital spec-
trophotometer providedwith 1 cmmatched silica quartz cells.
2.2. Reagents and Standards. Analytical reagent grade chem-
icals and reagents were used, and double distilled water was
used throughout the experiment to prepare all solutions.
(i) Standard NMD solution. The pharmaceutical grade
NMD certified to be 99.99% pure was received from
(Cipla Ltd., Mumbai, India) as a gift sample and
used as received. Accurately 10mg each of NMD
was weighed into a 100mL beaker and dissolved
NMD in 5mL acetone. To this, 5mL 4Nhydrochloric
acid and 1 g of zinc dust were added and shaken
thoroughly for about 15min and then diluted up to
the mark with water in a 100mL calibrated flask
(100 𝜇g/mL), and filter through Whatman number
41 filter paper. Working solutions were prepared as
required by dilution.
Pharmaceutical formulations of NMD such as
Nimodip (Cadila) and Nimotide (Micro synapse)
tablets and Modipin (Torrent) injection were pur-
chased from local markets.
(ii) Phloroglucinol [PG] [1% w/v]. It was prepared by
dissolving 1 g of the phloroglucinol (99.98%) (BDH
Chemicals Ltd., Poole, England) in 100mL distilled
water.
(iii) Others. Aqueous solutions of sodium nitrite [0.1%]
(Merck), sulfamic acid [3.0% w/v] (Qualigens), so-
dium hydroxide [4M] (Merck), and hydrochloric
acid [1M] (Merck) were prepared and used.
2.3. Preparation of Calibration Graph. Aliquot of nimodipine
ranging from 0 to 25 𝜇g/mL was transferred into a series of
10mL volumetric flasks. To each flask, 0.5mL sodium nitrite
(0.1% w/v) and 1mL of 1M hydrochloric acid were added.
After 3min, 0.5mL of sulfamic acid (3% w/v) was added to
each flask. Then, 1mL of phloroglucinol (1% w/v) and 1.5mL
4M sodium hydroxide were added. The contents were made
up to the mark with distilled water and mixed well. After
5min, the absorbance of the yellow colored azo dye was
measured at 410 nm against the reagent blank. The amount
of nimodipine present in the sample was computed from the
calibration curve.
2.4. Procedure for Commercial Samples
2.4.1. Procedure for Tablets. Twenty tablets were weighed
accurately and ground into a fine powder. Tablets powder
equivalent to 10mg of the NMD was accurately weighed and
dissolved in 5mL ofmethanol. To this, 5mL 4Nhydrochloric
acid and 1 g of zinc dust were added into a 100mL volumetric
flask and shaken thoroughly for about 30min. The volume
was made up to the mark with water, mixed well and



























































Figure 2: (a) Effect of reagent. (b) Effect of sodium nitrite. (c) Effect of Hydrochloric acid. (d) Effect of time.
aliquots of the drug solution were taken, and the proposed
standard procedure was followed for analysis of the drug
content.
2.4.2. Procedure for Injection. Nimodipine injection sample
such as Modipin (Torrent) was transferred into a 100mL
calibrated flask. Then, the volume was diluted to the mark
with distilled water and mixed well. The content of the flask
which was at a concentration of 100𝜇g/mL was subjected
to analysis by the procedure described above after suitable
dilution step.
3. Results and Discussion
3.1. Chemistry. In the developedmethod, the aromatic amino
group in reduced nimodipine undergoes diazotization with
nitrous acid and then couples the resulting diazonium salt
with phloroglucinol to form yellow colored azo dye and
exhibits absorption maximum (𝜆max) at 410 nm. The colored
azo dye formed is stable for more than 2 h. Two steps are
involved in the reaction that produces the colored azo dyes.
In the first step, reduced NMD is treated with nitrite solution
in hydrochloric acid medium and undergoes diazotization to
give diazonium ion. In the second step, the diazonium ion
is coupled with the coupling agent phloroglucinol to form
colored azo dyes in alkaline medium [17, 18]. Based on the
above observations, a simple spectrophotometric method to
the determination of NMD was developed and validated as
per the current ICH guidelines (see Scheme 1).
3.2. Optimization of Experimental Parameters. The various
experimental parameters, which influence the formation of
the colored azo dye, were optimized.
3.2.1. Effect of Reagents. In order to study the effect of con-
centration of phloroglucinol, a fixed concentration of NMD
(10 𝜇g/mL) was taken in a series of 10mL calibrated flasks,
and to that 0.5–3mL of phloroglucinol (1% w/v) was added
and studied by measuring the absorbance at specified wave-
lengths in the standard procedure. Optimization is done by
varying one parameter, keeping others constant. A volume
of 1mL phloroglucinol (1%) in a total volume of 10mL was
found to be sufficient leading to maximum color stability of








































Scheme 1: Proposed reaction scheme for NMD.
The constant absorbance readings were obtained in the
range 0.25–2.0mL of 0.1% sodium nitrite (Figure 2(b)).Thus,
0.5mL of sodium nitrite solution was used in a total volume
of 10mL of reaction mixture. The excess of nitrite could be
removed by the addition of 0.5mL of 3% sulfamic acid.
3.2.2. Effect of Acid Concentration. Diazotization was carried
out at room temperature, and cooling to 0–5∘C was not
necessary. The hydrochloric acid concentration was studied
(Figure 2(c)), and 1mL of 0.1M hydrochloric acid concentra-
tion was fixed for getting a stable diazonium ion in a 10mL
reaction mixture at room temperature (27 ± 3∘C).
3.2.3. Effects of Alkali. In the developed method, the opti-
mum concentration of sodium hydroxide leading to a max-
imum intensity of the yellow colored azo dye was found to
be 1mL of 4M in the final solution. Higher concentrations of
alkali may lead to partial decolorization of the dye.
3.2.4. Effects of Reaction Time and Stability of the Azo Dye.
Experiment was carried out to optimize the reaction time and
stability of the azo dye.The colored azo dye developed rapidly
after addition of the reagents and attainedmaximum intensity
after about 5min at room temperature. Stability study of the
azo dye was carried out by measuring the absorbance values
at time intervals of 10min andwas found to be stable formore
than 2 h (Figure 2(d)).
3.3.MethodValidation. Thespectrophotometricmethod val-
idation characteristics were tested in accordance with ICH
Table 2: Optical characteristics and precision.
Parameter Proposed method
𝜆max nm 410
Beer’s law range (𝜇g/mL) 0–25
Linearity range (𝜇g/mL) 0.2–23
Molar absorptivity (𝜀), (L/mol/cm) 1.23 × 104
Sandell’s sensitivity (𝜇g cm−2) 0.034
Intercept (𝑎) −0.014
Slope (𝑏) 0.030










𝑦 = 𝑏𝑐 + 𝑎 where 𝑐 is the concentration of NMD in 𝜇g/mL and 𝑦 is the
absorbance at 410 nm. 𝑆𝑎 is the standard deviation of intercept, and 𝑆𝑏 is the
standard deviation of slope.
[19, 20] guidelines. The proposed method was evaluated
under the optimum conditions with respect to linearity, ac-
curacy, precision,molar absorptivity, Sandell’s sensitivity, and
Student’s 𝑡-test.
3.3.1. Linearity, Detection, and Quantitation Limit. A linear
calibration graph was constructed using a standard solution
of NMD. Under established experimental conditions, a linear
correlation was found between the absorbance at 410 nm
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Table 3: Evaluation of intraday and interday accuracy and precision results.
NMD taken 𝜇g/mL Intraday
a Interdayb
NMD foundc𝜇g/mL Precisiond Accuracye NMD foundc𝜇g/mL Precisiond Accuracye
10 9.94 ± 0.09 0.86 0.62 9.87 ± 0.15 1.55 1.29
Proposed method 15 14.92 ± 0.05 0.30 0.53 14.77 ± 0.23 1.56 1.56
20 20.07 ± 0.05 0.25 −0.34 20.17 ± 0.33 1.62 −0.86
aMean value of five determinations; bmean value of five determinations; cmean value of three determinations; drelative standard deviation (%); ebias%: (found-
taken/taken) × 100.
Table 4: Results of determination of NMD in tablets and statistical comparison with the reference method.
Tablet brand name∗ Nominal amount mg per tablet Found
∗∗ (% of nominal amount ± SD)
Reference method [14] Method
Nimodipa 30mg 99.20 ± 0.38 100.27 ± 0.62
𝑡 = 0.11, 𝐹 = 2.68
Nimotideb 30mg 99.34 ± 0.43 100.54 ± 0.41
𝑡 = 0.12, 𝐹 = 0.89
Modipinc 30mg/injection 100.02 ± 0.53 100.28 ± 0.66
𝑡 = 0.03, 𝐹 = 1.53
∗Marketed by; aCadila; bMicro Synapse; cTorrent.
∗∗Mean value of five determinations.
Tabulated 𝑡- and 𝐹-values at 95% confidence level are 2.77 and 6.39, respectively.
and concentrations of NMD in the ranges given in Table 2.
Regression analysis of the calibration curve is described by
𝑌 = 𝑎 + 𝑏𝑥, (1)
where 𝑦 = absorbance, 𝑎 = intercept, 𝑏 = slope, and 𝑥 =
concentration, and the values are presented in Table 2. The
optical characteristics such as absorption maxima, Beer’s law
limit, molar absorptivity, and Sandell’s sensitivity values [21]
are also given in Table 2.
3.3.2. Accuracy and Precision
Precision and Accuracy. The intraday and interday precision
of the proposed method was established by replicate analysis
of NMD samples at three different concentrations (low,
medium, and high) (Table 3) within the working limits, each
being repeated five times. The percentage relative standard
deviation (% RSD) values of both intra- and interday studies
are shown in Table 3 were satisfactory and showed the
best appraisal of the procedures in daily use. Accuracy was
evaluated as percentage relative error (% RE) between the
measured mean concentrations and taken concentrations for
NMD. Bias {bias% = [(Concentration found-known con-
centration) × 100/known concentration]} was calculated
at each concentration, and the results obtained from this
investigation are also summarized in Table 3. The values
percentage relative error between the concentrations ofNMD
for taken and found less than 2% showed the high accuracy of
the proposedmethod.The proposedmethodwas successfully
applied to the determination of NMD in pharmaceutical
dosage forms.
3.3.3. Selectivity. The selectivity of the proposed method to
pharmaceutical samples was tested by a placebo blank and
syntheticmixture analyses. A placebo blank containing starch
(10mg), acacia (10mg), methyl cellulose (20mg), sodium
citrate (15mg), talc (15mg), magnesium stearate (10mg),
and sodium alginate (15mg) was prepared by combining
all components, and its solution was prepared as described
under “procedure for tablets” and was subjected to analysis
by following the general procedures. It was found that, there
was no interference from the common excipients added to the
tablets.
A synthetic mixture was separately prepared by adding
pure NMD (10mg) to placebo blank of similar composi-
tion and homogenized. The extract was prepared by taking
synthetic mixture containing NMD (10mg in 100mL) to
give NMD (100𝜇g/mL). Synthetic mixture solution prepared
above was taken at three different concentrations equivalent
to 10, 15, and 20𝜇g/mL and was subjected to analysis by
following the general procedure. The results of the study
indicate that the common excipients did not interfere with
the analysis by the proposed method and the results were
obtained in the range from 98% to 101.5%. These results
complemented the findings of the placebo blank analysis with
respect to selectivity.
3.3.4. Application to the Tablets and Injection. The proposed
method was applied successfully to the determination of
NMD in commercial tablets and injection. The same batch
tablets were also assayed by the reference method [14] which
consisted of measurement of absorbance of NMD at 550 nm.
The results of an assay were statistically compared with
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Table 5: Results of recovery by standard-addition method.
Tablet brand name NMD tablet 𝜇g/mL Pure NMD added 𝜇g/mL Total found 𝜇g/mL Pure NMD recovered∗%± SD
5 5 10.03 100.62 ± 0.38
Nimodip 5 10 14.97 99.76 ± 0.83
5 15 20.07 100.44 ± 0.65
5 5 10.05 101.05 ± 0.66
Nimotide 5 10 15.02 100.19 ± 0.33
5 15 20.05 100.35 ± 0.22
5 5 9.99 99.85 ± 0.53
Modipin 5 10 14.99 99.97 ± 0.69
5 15 20.15 101.01 ± 0.75
∗Mean value of three measurements.
the reference method [14] by applying the Student’s 𝑡-test
for accuracy and 𝐹-test for precision. The results in Table 4
showed that there is no significant difference between the
proposed and reference method [14] at the 95% confidence
level with respect to accuracy and precision.
3.3.5. Recovery. To further assess the accuracy of the pro-
posed method, recovery experiment was performed by
applying the standard addition technique. The recovery test
was done by adding nimodipine to the previously analyzed
tablets. The recovery of each drug was calculated by compar-
ing the concentration obtained from the spikedmixtures with
those of pure drugs. The results are summarized in Table 5.
4. Conclusions
In the present investigation, a simple, highly sensitive, accu-
rate, and precise spectrophotometric method for the routine
estimation of NMD in pure form, tablets, and injection is
described. The proposed method has better linear dynamic
ranges and sensitivity compared to the reported visible [10–
14] spectrophotometric method. The main advantages of the
established method are as follow.
(i) Diazotization was carried out at room temperature,
and cooling to 0–5∘C was not necessary.
(ii) The amount of the reagents used in the reaction is
minimum. In addition, organic solvent are not used
in the determination.
Furthermore, the proposed method does not require
elaborate procedures, which are usually associated with
chromatographic methods and other traditional extractive
spectrophotometric methods. The methods are unaffected
by slight variations in the experimental conditions such
as basicity, reagent concentrations, and temperature. These
advantages give the proposed method a great value andmake
it applicable for the analysis of NMD in routine quality
control pharmaceutical laboratories.
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